Download
12012_2024_Article_9872.pdf 4,00MB
WeightNameValue
1000 Titel
  • Electrophysiological Profile of Different Antiviral Therapies in a Rabbit Whole-Heart Model
1000 Autor/in
  1. Wolfes, Julian |
  2. Kirchner, Lina |
  3. Doldi, Florian |
  4. Wegner, Felix |
  5. Rath, Benjamin |
  6. Eckardt, Lars |
  7. Ellermann, Christian |
  8. Frommeyer, Gerrit |
1000 Verlag Springer US
1000 Erscheinungsjahr 2024
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2024-06-08
1000 Erschienen in
1000 Quellenangabe
  • 24(7):656-666
1000 Copyrightjahr
  • 2024
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1007/s12012-024-09872-3 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11211193/ |
1000 Publikationsstatus
1000 Begutachtungsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • <jats:title>Abstract</jats:title><jats:p>Antiviral therapies for treatment of COVID-19 may be associated with significant proarrhythmic potential. In the present study, the potential cardiotoxic side effects of these therapies were evaluated using a Langendorff model of the isolated rabbit heart. 51 hearts of female rabbits were retrogradely perfused, employing a Langendorff-setup. Eight catheters were placed endo- and epicardially to perform an electrophysiology study, thus obtaining cycle length-dependent action potential duration at 90% of repolarization (APD<jats:sub>90</jats:sub>), QT intervals and dispersion of repolarization. After generating baseline data, the hearts were assigned to four groups: In group 1 (HXC), hearts were treated with 1 µM hydroxychloroquine. Thereafter, 3 µM hydroxychloroquine were infused additionally. Group 2 (HXC + AZI) was perfused with 3 µM hydroxychloroquine followed by 150 µM azithromycin. In group 3 (LOP) the hearts were perfused with 3 µM lopinavir followed by 5 µM and 10 µM lopinavir. Group 4 (REM) was perfused with 1 µM remdesivir followed by 5 µM and 10 µM remdesivir. Hydroxychloroquine- and azithromycin-based therapies have a significant proarrhythmic potential mediated by action potential prolongation and an increase in dispersion. Lopinavir and remdesivir showed overall significantly less pronounced changes in electrophysiology. In accordance with the reported bradycardic events under remdesivir, it significantly reduced the rate of the ventricular escape rhythm.</jats:p>
1000 Sacherschließung
lokal Adenosine Monophosphate/pharmacology [MeSH]
gnd 1206347392 COVID-19
lokal Arrhythmia
lokal Hydroxychloroquine/toxicity [MeSH]
lokal Alanine/pharmacology [MeSH]
lokal Action Potentials/drug effects [MeSH]
lokal Heart/drug effects [MeSH]
lokal COVID-19 Drug Treatment [MeSH]
lokal Hydroxychloroquine/pharmacology [MeSH]
lokal Heart Rate/drug effects [MeSH]
lokal Anitviral
lokal Rabbits [MeSH]
lokal Antiviral Agents/toxicity [MeSH]
lokal Alanine/analogs
lokal Female [MeSH]
lokal Remdesivir
lokal Lopinavir
lokal Arrhythmias, Cardiac/physiopathology [MeSH]
lokal Animals [MeSH]
lokal Adenosine Monophosphate/analogs
lokal Arrhythmias, Cardiac/chemically induced [MeSH]
lokal Antiviral Agents/pharmacology [MeSH]
lokal Azithromycin
lokal Sudden cardiac death
lokal Hydroxychloroquine
lokal Long QT syndrome
lokal Research
lokal Cardiotoxicity [MeSH]
lokal Adenosine Monophosphate/toxicity [MeSH]
lokal Isolated Heart Preparation [MeSH]
1000 Fächerklassifikation (DDC)
1000 Liste der Beteiligten
  1. https://frl.publisso.de/adhoc/uri/V29sZmVzLCBKdWxpYW4=|https://frl.publisso.de/adhoc/uri/S2lyY2huZXIsIExpbmE=|https://frl.publisso.de/adhoc/uri/RG9sZGksIEZsb3JpYW4=|https://frl.publisso.de/adhoc/uri/V2VnbmVyLCBGZWxpeA==|https://frl.publisso.de/adhoc/uri/UmF0aCwgQmVuamFtaW4=|https://frl.publisso.de/adhoc/uri/RWNrYXJkdCwgTGFycw==|https://frl.publisso.de/adhoc/uri/RWxsZXJtYW5uLCBDaHJpc3RpYW4=|https://frl.publisso.de/adhoc/uri/RnJvbW1leWVyLCBHZXJyaXQ=
1000 Hinweis
  • DeepGreen-ID: 61c790ba0dc546d191be16dce78cfebe ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Förderer
  1. Universitätsklinikum Münster |
1000 Fördernummer
  1. -
1000 Förderprogramm
  1. -
1000 Dateien
1000 Förderung
  1. 1000 joinedFunding-child
    1000 Förderer Universitätsklinikum Münster |
    1000 Förderprogramm -
    1000 Fördernummer -
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6496450.rdf
1000 Erstellt am 2025-02-04T13:42:49.144+0100
1000 Erstellt von 322
1000 beschreibt frl:6496450
1000 Zuletzt bearbeitet 2025-09-12T05:10:22.902+0200
1000 Objekt bearb. Fri Sep 12 05:10:22 CEST 2025
1000 Vgl. frl:6496450
1000 Oai Id
  1. oai:frl.publisso.de:frl:6496450 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source